A detailed history of Cognios Beta Neutral Large Cap Fund, LP transactions in Incyte Corp stock. As of the latest transaction made, Cognios Beta Neutral Large Cap Fund, LP holds 8,481 shares of INCY stock, worth $589,938. This represents 0.65% of its overall portfolio holdings.

Number of Shares
8,481
Previous 9,318 8.98%
Holding current value
$589,938
Previous $585,000 17.44%
% of portfolio
0.65%
Previous 0.79%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$56.55 - $66.59 $47,332 - $55,735
-837 Reduced 8.98%
8,481 $483,000
Q4 2023

Feb 02, 2024

BUY
$52.16 - $64.19 $24,410 - $30,040
468 Added 5.29%
9,318 $585,000
Q3 2023

Nov 06, 2023

BUY
$57.77 - $65.93 $30,906 - $35,272
535 Added 6.43%
8,850 $511,000
Q2 2023

Aug 03, 2023

SELL
$60.95 - $75.51 $41,872 - $51,875
-687 Reduced 7.63%
8,315 $517,000
Q1 2023

May 02, 2023

BUY
$70.23 - $86.01 $632,210 - $774,262
9,002 New
9,002 $650,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cognios Beta Neutral Large Cap Fund, LP Portfolio

Follow Cognios Beta Neutral Large Cap Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cognios Beta Neutral Large Cap Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cognios Beta Neutral Large Cap Fund, LP with notifications on news.